Healthtech innovation continues to play a critical role in advancing healthcare solutions globally. With the increasing demand for more efficient, scalable, and patient-centric tools, startups in this space are driving change through new technologies and approaches.
We are pleased to share that Longenesis, a portfolio company of LongeVC, has won the Supernova Challenge 2.0, the world's largest early-stage startup pitch competition at Expand North Star 2024, securing a $100,000 prize. Their solutions stand as a strong example of how the intersection of biotechnology and data science can create impactful advancements for the future of healthcare.
For more details on the pitch contest, visit the page here.
To learn more about Longenesis, visit their website here.
We are pleased to share that Longenesis, a portfolio company of LongeVC, has won the Supernova Challenge 2.0, the world's largest early-stage startup pitch competition at Expand North Star 2024, securing a $100,000 prize. Their solutions stand as a strong example of how the intersection of biotechnology and data science can create impactful advancements for the future of healthcare.
For more details on the pitch contest, visit the page here.
To learn more about Longenesis, visit their website here.